Registered entities
Enterprise Therapeutics Limited
Reg. No. UK09022750United Kingdom
ENTERPRISE THERAPEUTICS LTD
Reg. No. 9022750United Kingdom
Innovation
20 patent families (5 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 704 times.
| Year | Filings |
|---|---|
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 12 |
| 2020 | 7 |
| 2021 | 9 |
| 2022 | 3 |
| 2023 | 4 |
| 2024 | 5 |
| 2025 | 2 |
Social engagement
Social engagement: 2.7K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
9 investors on record; lead investors include Versant Ventures, Novartis Venture Fund, Panakes Partners.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 56% |
| Accelerator & incubator | 1 | 11% |
| Bank & private debt | 1 | 11% |
| Other / undisclosed | 2 | 22% |
Recent activity
26 May 2026
Event
49th ECFS European Cystic Fibrosis conference
22 May 2026
Event
Milan Longevity Summit
19 May 2026
Event
American Thoracic Society annual conference